6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 04 Mar 2026
- Reporting date
- 04 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
GSK plc reports
- Company location
- London
GSK plc has filed 6,789 SEC EDGAR filings since 12 Jan 2001
SEC filing history
Showing 126-150 of 1,000 matching filings.
Per page
25
Current page
6
6-K
File 001-15170
GSK COMPLETES ACQUISITION OF RAPT THERAPEUTICS
- Filing date
- 03 Mar 2026
- Reporting date
- 03 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 03 Mar 2026
- Reporting date
- 03 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC TO-T/A
SC TO-T/A
- Filing date
- 03 Mar 2026
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 02 Mar 2026
- Reporting date
- 02 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TOTAL VOTING RIGHTS
- Filing date
- 02 Mar 2026
- Reporting date
- 02 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 27 Feb 2026
- Reporting date
- 27 Feb 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 27 Feb 2026
- Reporting date
- 27 Feb 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
LINERIXIBAT ACCEPTED FOR PRIORITY REVIEW IN CHINA
- Filing date
- 26 Feb 2026
- Reporting date
- 26 Feb 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
BEPIROVIRSEN ACCEPTED FOR JAPAN REGULATORY REVIEW
- Filing date
- 26 Feb 2026
- Reporting date
- 26 Feb 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 26 Feb 2026
- Reporting date
- 26 Feb 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 25 Feb 2026
- Reporting date
- 25 Feb 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 25 Feb 2026
- Reporting date
- 25 Feb 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
GSK ENTERS AGREEMENT TO ACQUIRE 35PHARMA
- Filing date
- 25 Feb 2026
- Reporting date
- 25 Feb 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 25 Feb 2026
- Reporting date
- 25 Feb 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 24 Feb 2026
- Reporting date
- 24 Feb 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 24 Feb 2026
- Reporting date
- 24 Feb 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
SC TO-T/A
SC TO-T/A
- Filing date
- 24 Feb 2026
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 23 Feb 2026
- Reporting date
- 23 Feb 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 20 Feb 2026
- Reporting date
- 20 Feb 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 20 Feb 2026
- Reporting date
- 20 Feb 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 19 Feb 2026
- Reporting date
- 19 Feb 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 19 Feb 2026
- Reporting date
- 19 Feb 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 18 Feb 2026
- Reporting date
- 18 Feb 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 17 Feb 2026
- Reporting date
- 17 Feb 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing